Regeneron Pharmaceuticals
A Senior Manager, Expanded Access Programs oversees operational aspects of multiple programs including Expanded Access Programs, individual patient access, and post-trial access. The role involves managing budgets, drug supply, metrics, vendor management, and cross-functional systems to support program success.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
27% above the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Site Manager, Expanded Access Programs
myTomorrows
Site Manager, Expanded Access Programs
myTomorrows
Expanded Access Program Coordinator
McCauley Constructors Inc
Expanded Access Program Coordinator
McCauley Constructors Inc
Sr. Manager, Field Medical
Rhythm Pharmaceuticals
Expanded Access Manager / Post-Trial Access Specialist - FSP - UK
lifelancer